PRQR
ProQR Therapeutics N.V.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
—
—
ProQR Therapeutics N.V.
1.43
No thesis.
Expected move
No implied move.
Linked news
NewsNews
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Adage Capital Partners GPAdage Capital Partners GP | $16.8M | 14.97% | +44.17% | |
| 2 | Standard Life AberdeenStandard Life Aberdeen | $16.6M | 14.83% | +169.30% | |
| 3 | Affinity Asset AdvisorsAffinity Asset | $10.3M | 9.21% | +125.89% | |
| 4 | Privium Fund Management B.V.Privium Fund Management B.V. | $10.3M | 9.17% | +0.97% | |
| 5 | Ikarian CapitalIkarian Capital | $6.4M | 5.69% | +129.58% | |
| 6 | Woodline PartnersWoodline Partners | $6.1M | 5.44% | new | |
| 7 | Heights Capital ManagementHeights | $5.1M | 4.59% | new | |
| 8 | Morgan StanleyMorgan Stanley | $3.3M | 2.93% | +35.96% | |
| 9 | Sphera Funds ManagementSphera Funds | $3.3M | 2.92% | new | |
| 10 | Kynam Capital ManagementKynam | $2.9M | 2.60% | 0.00% | |
| 11 | DAFNA Capital ManagementDAFNA | $2.8M | 2.54% | −2.37% | |
| 12 | Squadron Capital ManagementSquadron | $2.8M | 2.51% | new | |
| 13 | 683 Capital Management683 Capital Management | $2.6M | 2.31% | new | |
| 14 | Citadel AdvisorsCitadel | $2.2M | 1.97% | +68.39% | |
| 15 | Platinum Investment ManagementPlatinum | $2.2M | 1.93% | −6.16% | |
| 16 | Two Sigma InvestmentsTwo Sigma | $2.1M | 1.89% | +23.93% | |
| 17 | Eversept PartnersEversept Partners | $1.9M | 1.70% | new | |
| 18 | Boothbay Fund ManagementBoothbay Fund | $1.8M | 1.58% | +167.04% | |
| 19 | Diadema PartnersDiadema Partners | $1.7M | 1.54% | +414.22% | |
| 20 | UBS GroupUBS | $1.2M | 1.06% | +109.41% | |
| 21 | Delaware Management HoldingsDelaware | $1.2M | 1.03% | 0.00% | |
| 22 | M28 Capital ManagementM28 Capital Management | $1.1M | 1.00% | 0.00% | |
| 23 | Raymond James FinancialRaymond James Financial | $1.1M | 0.95% | +4.58% | |
| 24 | Jane Street GroupJane Street | $846,493 | 0.76% | +1267.13% | |
| 25 | StemPoint CapitalStemPoint Capital | $801,760 | 0.72% | new |
69 managers report $112.0M of ProQR Therapeutics on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Adage Capital Partners GP is largest at 14.97%.